Ameritas Investment Partners’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-105
| Closed | -$1.82K | – | 3253 |
|
|
2024
Q1 | $1.82K | Hold |
105
| – | – | ﹤0.01% | 3033 |
|
|
2023
Q4 | $1.64K | Hold |
105
| – | – | ﹤0.01% | 3066 |
|
|
2023
Q3 | $5.18K | Hold |
105
| – | – | ﹤0.01% | 2983 |
|
|
2023
Q2 | $8.19K | Hold |
105
| – | – | ﹤0.01% | 2959 |
|
|
2023
Q1 | $9.49K | Hold |
105
| – | – | ﹤0.01% | 2743 |
|
|
2022
Q4 | $12.4K | Hold |
105
| – | – | ﹤0.01% | 2750 |
|
|
2022
Q3 | $18K | Hold |
105
| – | – | ﹤0.01% | 2579 |
|
|
2022
Q2 | $9K | Hold |
105
| – | – | ﹤0.01% | 2871 |
|
|
2022
Q1 | $16K | Hold |
105
| – | – | ﹤0.01% | 2655 |
|
|
2021
Q4 | $31K | Hold |
105
| – | – | ﹤0.01% | 2426 |
|
|
2021
Q3 | $60K | Hold |
105
| – | – | ﹤0.01% | 2039 |
|
|
2021
Q2 | $48K | Hold |
105
| – | – | ﹤0.01% | 2214 |
|
|
2021
Q1 | $56K | Buy |
105
+39
| +59% | +$20.8K | ﹤0.01% | 2022 |
|
|
2020
Q4 | $59K | Hold |
66
| – | – | ﹤0.01% | 1888 |
|
|
2020
Q3 | $42K | Buy |
+66
| New | +$42K | ﹤0.01% | 1946 |
|